23andMe Holding Co - Ordinary Shares - Class A

NASDAQ:ME

0.46

+0.01 (+1.11%)

7:39:35 PM EDT: $0.47 +0.01 (+1.19%)

Market Cap (Intraday)	224.12M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$61.45 Million
Adjusted EPS	-$0.15

See more estimates

10-Day MA	$0.46
50-Day MA	$0.52
200-Day MA	$0.90

See more pivots

23andMe Holding Co - Ordinary Shares - Class A Stock, NASDAQ:ME

349 Oyster Point Boulevard, South San Francisco, California 94080

United States of America

Phone: +1.650.938.6300

Number of Employees: 816

http://www.23andme.com

Description

23andMe Holding Co. is a consumer genetics and research company, which engages in assisting people to access, understand, and benefit from the human genome. It operates through the Consumer and Research Services, and Therapeutics segments. The Consumer and Research Services segment consists of Personal Genome Service, Telehealth Business, and Research Services. The Therapeutics segment focuses on the genetic insights of genetic and phenotypic information. The company was founded by Anne E. Wojcickiin 2006 and is headquartered in South San Francisco, CA.